These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19466541)
41. A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element. Atlas E; Stramwasser M; Mueller CR Oncogene; 2001 Oct; 20(48):7110-4. PubMed ID: 11704836 [TBL] [Abstract][Full Text] [Related]
42. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
43. Kaiso interacts with p120-catenin to regulate β-catenin expression at the transcriptional level. Liu Y; Dong QZ; Wang S; Xu HT; Miao Y; Wang L; Wang EH PLoS One; 2014; 9(2):e87537. PubMed ID: 24498333 [TBL] [Abstract][Full Text] [Related]
44. XAF1 is frequently methylated in human esophageal cancer. Chen XY; He QY; Guo MZ World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195 [TBL] [Abstract][Full Text] [Related]
45. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac. Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117 [TBL] [Abstract][Full Text] [Related]
46. Molecular cloning and characterization of human acid sensing ion channel (ASIC)2 gene promoter. Xia J; Zhou ZH; Bubien JK; Fuller CM; Markert JM; Mapstone TB; Gillespie GY; Benos DJ Gene; 2003 Aug; 313():91-101. PubMed ID: 12957380 [TBL] [Abstract][Full Text] [Related]
47. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Jhaveri MS; Morrow CS Gene; 1998 Mar; 210(1):1-7. PubMed ID: 9524203 [TBL] [Abstract][Full Text] [Related]
48. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region. Al-Nakhle H; Smith L; Bell SM; Burns PA; Cummings M; Hanby AM; Lane S; Parker MD; Hughes TA; Speirs V Int J Oncol; 2013 Dec; 43(6):2039-45. PubMed ID: 24068253 [TBL] [Abstract][Full Text] [Related]
49. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. Meng CF; Zhu XJ; Peng G; Dai DQ World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755 [TBL] [Abstract][Full Text] [Related]
50. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer. Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012 [TBL] [Abstract][Full Text] [Related]
51. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368 [TBL] [Abstract][Full Text] [Related]
52. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
53. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104 [TBL] [Abstract][Full Text] [Related]
54. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193 [TBL] [Abstract][Full Text] [Related]
55. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors. Mavis CK; Morey Kinney SR; Foster BA; Karpf AR Prostate; 2009 Sep; 69(12):1312-24. PubMed ID: 19444856 [TBL] [Abstract][Full Text] [Related]
56. Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines. Tost J; Hamzaoui H; Busato F; Neyret A; Mourah S; Dupont JM; Bouizar Z Epigenetics; 2011 Aug; 6(8):1035-46. PubMed ID: 21775817 [TBL] [Abstract][Full Text] [Related]
57. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735 [TBL] [Abstract][Full Text] [Related]
58. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma. Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972 [TBL] [Abstract][Full Text] [Related]
59. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells. Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215 [TBL] [Abstract][Full Text] [Related]
60. Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers. Yun J; Song SH; Park J; Kim HP; Yoon YK; Lee KH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY Lab Invest; 2012 Jul; 92(7):1033-44. PubMed ID: 22508389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]